Fexinidazole for human African trypanosomiasis: the challenge of accessibility

EM Miaka; CP Pasi; E Hasker

doi:10.1016/S2214-109X(25)00068-3

Fexinidazole for human African trypanosomiasis: the challenge of accessibility

EM Miaka, CP Pasi, E Hasker

Mycobacterial Diseases and Neglected Tropical Diseases

Research output: Contribution to journal › Editorial › peer-review

Original language	English
Journal	Lancet Global Health
Volume	13
Issue number	5
Pages (from-to)	e789-e790
Number of pages	2
ISSN	2214-109X
DOIs	https://doi.org/10.1016/S2214-109X(25)00068-3
Publication status	Published - May-2025

Access to Document

10.1016/S2214-109X(25)00068-3Licence: CC BY-NC-ND

Cite this

@article{dc4ae3d850934182a62ea7026a7152ed,

title = "Fexinidazole for human African trypanosomiasis: the challenge of accessibility",

author = "EM Miaka and CP Pasi and E Hasker",

note = "FTX; DOAJ; (CC BY NC ND)",

year = "2025",

month = may,

doi = "10.1016/S2214-109X(25)00068-3",

language = "English",

volume = "13",

pages = "e789--e790",

journal = "Lancet Global Health",

issn = "2214-109X",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Fexinidazole for human African trypanosomiasis: the challenge of accessibility

AU - Miaka, EM

AU - Pasi, CP

AU - Hasker, E

N1 - FTX; DOAJ; (CC BY NC ND)

PY - 2025/5

Y1 - 2025/5

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=itm_wosliteitg&SrcAuth=WosAPI&KeyUT=WOS:001480849100001&DestLinkType=FullRecord&DestApp=WOS_CPL

U2 - 10.1016/S2214-109X(25)00068-3

DO - 10.1016/S2214-109X(25)00068-3

M3 - Editorial

C2 - 40288385

SN - 2214-109X

VL - 13

SP - e789-e790

JO - Lancet Global Health

JF - Lancet Global Health

IS - 5

ER -

Fexinidazole for human African trypanosomiasis: the challenge of accessibility

Access to Document

Other files and links

Cite this